Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | QSR | MCD |
|---|---|---|
| Price | $69.90 | $232.13 |
| Change today | ▼ 1.66% | ▲ 0.51% |
| Market cap | $24.38B | $164.27B |
| Return, 3 months | -1.3% | -13.2% |
| Return, year to date | +5.2% | -22.6% |
| Return, 1 year | +9.5% | -20.8% |
| P/E (TTM) | 18.8 | 18.9 |
| P/B | 6.3 | -160.5 |
| P/E percentile vs own 5y | – | 0th |
| Dividend yield | 3.63% | 3.17% |
| Revenue growth (YoY, latest qtr) | – | +3.8% |
| Net profit growth (YoY) | – | +4.8% |
| Gross margin | – | 57.4% |
| Operating margin | – | 45.7% |
| Net margin | – | 31.7% |
| Return on equity | – | – |
| Analyst target vs. price | – | +28.4% |
| Analyst buy share | – | 58% |
| RSI (14) | 35 | 22 |
| 30-day volatility | 24.9% | 20.3% |
| Max drawdown, 1 year | -12.5% | -31.0% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
